Page 234 - Biodegradable Polyesters
P. 234
212 8 Systematic Development of Electrospun PLA/PCL Fiber Hybrid Mats
fibers with paracetamol inoculation. 62. Haroosh, H.J., Chaudhary, D., and Dong,
Biomacromolecules, 7, 1623–1629. Y. (2012) Electrospun PLA/PCL fibers
53. Im,J., Yun, J.,Lim,Y., Kim, H.,and Lee, with tubular nanoclay: morphological
Y. (2010) Fluorination of electrospun and structural analysis. J. Appl. Polym.
hydrogel fibers for a controlled release Sci., 124, 3930–3939.
drug delivery system. Actabiomaterialia, 63. Haroosh, H.J., Dong, Y., Chaudhary,
6, 102–109. D., Ingram, G., and Yusa, S. (2013)
54. Fernandes, J., Correia, D., Botelho, G., Electrospun PLA: PCL composites
Padrão, J., Dourado, F., Ribeiro, C., embedded with unmodified and 3-
Lanceros-Méndez, S., and Sencadas, aminopropyltriethoxysilane (ASP)
V. (2014) PHB-PEO electrospun fiber modified halloysite nanotubes (HNT).
membranes containing chlorhexidine for Appl. Phys. A: Mater. Sci. Process., 110,
drug delivery applications. Polym. Test., 433–442.
34, 64–71. 64. Spasova, M., Stoilova, O., Manolova,
55. Yang, D., Li, Y., and Nie, J. (2007) Prepa- N., Rashkov, I., and Altankov, G. (2007)
ration of gelatin/PVA nanofibers and Preparation of PLLA/PEG nanofibers
their potential application in controlled by electrospinning and potential appli-
release of drugs. Carbohydr. Polym., 69, cations. J. Bioact. Compat. Polym., 22,
538–543. 62–76.
56. Liu, S., Kau, Y., Chou, C., Chen, J., Wu, 65. Haroosh H.J., Chaudhary D., and Yusa
R., and Yeh, W. (2010) Electrospun S. (2011) Effect of halloysite on elec-
PLGA/collagen nanofibrous membrane trospinning of PLA/PCL nanofibres.
as early-stage wound dressing. J. Membr. Proceedings of CHEMECA 2011 Con-
Sci., 355, 53–59. ference, Sydney, Australia, September
57. Hamori, M., Yoshimatsu, S., Hukuchi, Y., 18–21, 2011.
Shimizu, Y., Fukushima, K., Sugioka, N., 66. Haroosh H.J., Chaudhary D., and Dong
Nishimura, A., and Shibata, N. (2014) Y. (2011) Effect of solution parame-
Preparation and pharmaceutical evalua- ters on electrospun PLA/PCL fibers.
tion of nano-fiber matrix supported drug Proceedings of CHEMECA 2011 Con-
delivery system using the solvent-based ference, Sydney, Australia, September
electrospinning method. Int. J. Pharm., 18–21, 2011.
464, 243–251. 67. Haroosh, H.J., Dong, Y., and Ingram,
58. Sabitha, M. and Rajiv, S. (2014) G. (2013) Synthesis, morphological
Preparation and characterization of structures, and material characteriza-
ampicillin-incorporated electrospun tion of electrospun PLA: PCL/magnetic
polyurethane scaffolds for wound healing nanoparticle composites for drug deliv-
and infection control. Polym. Eng. Sci. ery. J. Polym. Sci.,PartB:Polym.Phys.,
doi: 10.1002/pen.23917 51, 1607–1617.
59. Haroosh, H., Chaudhary, D., Dong, Y., 68. Haroosh, H.J., Chaudhary, D., and
and Hawkins, B (2011) Electrospun PLA: Ingram, G. (2011) Effect of solution
PCL/halloysite nanotube nanocomposites concentration and co-solvent ratio on
fibers for drug delivery. Proceedings electrospun PEG fibers. Proceedings of
of the Nineteenth International Con- CHEMECA 2011 Conference, Sydney,
ference on Processing and Fabrication Australia, September 18–21, 2011.
of Advanced Materials (PFAM XIX), 69. Shen,X., Yu,D., Zhu, L.,
Auckland, New Zealand, January 14–17, Branford-White, C., White, K., and
2011. Chatterton, N.P. (2011) Electrospun
®
60. Haroosh, H.J. (2014) Investigating novel diclofenac sodium loaded Eudragit L
biopolymeric nanostructures for drug 100-55 nanofibers for colon-targeted
delivery.PhD thesis.Departmentof drug delivery. Int. J. Pharm., 408,
Chemical Engineering, Curtin University. 200–207.
61. Chittur, K.K. (1998) FTIR/ATR for pro- 70. Kim, K., Luu, Y., Chang, C., Fang, D.,
tein adsorption to biomaterial surfaces. Hsiao, B., Chu, B., and Hadjiargyrou,
Biomaterials, 19, 357–369. M. (2004) Incorporation and controlled